Herbicidal compounds

By designing novel herbicidal phenoxypyridine compounds with specific heterocyclic substituents and halogen groups, the problem of insufficient crop selectivity of existing herbicides is solved, and efficient killing of target weeds and protection of useful crops is achieved. .

CN112996780BActive Publication Date: 2024-11-08SYNGENTA CROP PROTECITON AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201980072361.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2018-11-05
Filing Date
2019-11-01
Publication Date
2024-11-08
Estimated Expiration
2039-11-01

AI Technical Summary

Technical Problem

Existing herbicides have shortcomings in crop selectivity, making it difficult to effectively distinguish between target weeds and useful crops, resulting in unnecessary damage to the crops.

Method used

A novel herbicidal phenoxypyridine compound has been developed, with a structure specific to improving crop selectivity, and through specific heterocyclic substituents and halogen groups designs, improving the killing efficacy of target weeds while reducing the use of useful crops. toxicity.

Benefits of technology

It significantly improves the killing effect of weeds, while reducing damage to useful crops, significantly improving crop selectivity and ensuring crop safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN112996780B_ABST
    Figure CN112996780B_ABST
Patent Text Reader

Abstract

The present invention relates to compounds of formula (I) or agronomically acceptable salts of said compounds, wherein Q, R 1 , R 2 , n and m are as defined herein. The present invention further relates to herbicidal compositions comprising compounds of formula (I), and to the use of compounds of formula (I) for controlling weeds, in particular in crops of useful plants. #imgabs0#
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention relates to novel herbicidal compounds, to processes for their preparation, to herbicidal compositions comprising the novel compounds, and to their use for controlling weeds, in particular in crops of useful plants, or for inhibiting plant growth.

[0002] Herbicidal heteroaryl-substituted phenoxypyrimidines are disclosed, for example, in WO94 / 17059, WO2015 / 089003 and WO2015 / 108779. The present invention relates to novel herbicidal phenoxypyridine compounds which show improved properties compared to known pyrimidine compounds - in particular improved crop selectivity.

[0003] Therefore, according to the present invention, there is provided a compound having the formula (I):

[0004]

[0005] or an agronomically acceptable salt thereof,

[0006] in

[0007] Q is a 5-membered aromatic heterocyclic ring, which is optionally substituted by 1 or 2 R independently selected from the group consisting of 3 Substituents: C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, cyclopropyl, C1-C4 haloalkyl, C1-C2 alkoxy-, C1-C2 haloalkoxy-, halogen, -C(O)C1-C4 alkyl, NO2, -CH2CN, -CN and -S(O) p C1-C4 alkyl;

[0008] Each R 1 independently selected from the group consisting of halogen, -CN, nitro, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 haloalkyl, C1-C4 alkoxy-, C1-C4 haloalkoxy-, and -S(O) p C1-C4 alkyl;

[0009] Each R 2 independently selected from the group consisting of halogen, -CN, NO2, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C2-C4 alkenyl, C2-C4 alkynyl, -S(O) p C1-C4 alkyl, C1-C4 alkoxy, -C(O)C1-C4 alkyl, -C(O)OC1-C4 alkyl and C1-C4 haloalkoxy;

[0010] m = 0, 1 or 2;

[0011] n = 0, 1 or 2; and

[0012] p = 0, 1, or 2

[0013] provided that Q is not 1,3,4-oxadiazol-2-yl or C-attached tetrazolyl, and wherein if Q is 2-thienyl or 2-furyl, the 2-thienyl or 2-furyl is replaced by 1 or 2 R independently selected from the group consisting of C1-C2 haloalkyl, halogen and -CN 3 replace.

[0014] C1-C4 alkyl - includes, for example, methyl (Me, CH3), ethyl (Et, C2H5), n-propyl (n-Pr), isopropyl (i-Pr), n-butyl (n-Bu), isobutyl (i-Bu), sec-butyl and tert-butyl (t-Bu). C1-C2 alkyl is methyl (Me, CH3) or ethyl (Et, C2H5).

[0015] Halogen (or halo) includes, for example, fluorine, chlorine, bromine or iodine. The halogen (or halo) is correspondingly applied to halogen in other definition contexts, such as haloalkyl.

[0016] C1-C4 haloalkyl - includes, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1,1-difluoro-2,2,2-trichloroethyl, 2,2,3,3-tetrafluoropropyl and 2,2,2-trichloroethyl, heptafluoro-n-propyl and perfluoro-n-hexyl. C1-C2 haloalkyl is, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, or 1,1-difluoro-2,2,2-trichloroethyl.

[0017] The C1-C2 alkoxy group is a methoxy group or an ethoxy group.

[0018] C1-C2 haloalkoxy - includes, for example, fluoromethoxy, difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 1,1,2,2-tetrafluoroethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2,2-difluoroethoxy or 2,2,2-trichloroethoxy, preferably difluoromethoxy, 2-chloroethoxy or trifluoromethoxy.

[0019] C3-C6 cycloalkyl - includes cyclopropyl (c-propyl (c-Pr)), cyclobutyl (c-butyl (c-Bu)), cyclopentyl (c-pentyl) and cyclohexyl (c-hexyl).

[0020] C2-C4alkenyl- includes, for example, -CH=CH2 (vinyl) and -CH2-CH=CH2 (allyl).

[0021] C2-C4 alkynyl - includes, for example, -C≡CH (ethynyl) and -CH2-C≡CH (propargyl).

[0022] The C1-C4 alkyl-S-(alkylthio) includes, for example, methylthio, ethylthio, propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio or tert-butylthio, preferably methylthio or ethylthio.

[0023] The C1-C4 alkyl-S(O)-(alkylsulfinyl) includes, for example, methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl, isobutylsulfinyl, sec-butylsulfinyl or tert-butylsulfinyl, preferably methylsulfinyl or ethylsulfinyl.

[0024] The C1-C4 alkyl-S(O)2-(alkylsulfonyl) includes, for example, methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl or tert-butylsulfonyl, preferably methylsulfonyl or ethylsulfonyl.

[0025] In one embodiment of the present invention, there is provided a compound having formula (I), wherein n is 0. In another embodiment of the present invention, there is provided a compound having formula (I), wherein n is 1 or 2, and each R 1 is independently selected from the group consisting of halogen, -CN, nitro, C1-C2 alkyl, C1-C2 haloalkyl, C1-C2 alkoxy and C1-C2 haloalkoxy-. In a preferred embodiment of the present invention, there is provided a compound of formula (I) wherein n is 1 and R 1 is halogen (especially fluorine, chlorine or bromine) or CN. In a particularly preferred embodiment of the present invention, there is provided a compound of formula (I) wherein n is 1 and R 1 It is fluorine, especially 3-fluorine.

[0026] In another embodiment of the present invention, a compound of formula (I) is provided, wherein m=0. In another embodiment of the present invention, a compound of formula (I) is provided, wherein m is 1 or 2. In a preferred embodiment of the present invention, a compound of formula (I) is provided, wherein m is 1 or 2, and each R 2 is independently selected from the group consisting of halogen (especially fluorine, chlorine or bromine), nitro, -CN and C1-C4 haloalkyl (especially trifluoromethyl). In a particularly preferred embodiment of the present invention, there is provided a compound of formula (I) wherein m is 1 or 2, and each R 2 Independently selected from the group consisting of fluoro, chloro, bromo, nitro, -CN and trifluoromethyl.

[0027] In another embodiment of the present invention, there is provided a compound having formula (I), wherein Q is selected from the group consisting of:

[0028]

[0029] Where R 3 Selected from the group consisting of: hydrogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, cyclopropyl, C1-C2 haloalkyl, C1-C2 alkoxy-, C1-C2 haloalkoxy-, halogen, -C(O)C1-C4 alkyl, NO2, -CH2CN, -CN and -S(O) p C1-C4 alkyl; and

[0030] R 3a It is hydrogen or C1-C2 alkyl.

[0031] In a preferred embodiment of the present invention, Q is Q19, Q20 or Q34.

[0032] In another embodiment of the present invention, there is provided a compound having formula (I), wherein R 3 is a C1-C2 haloalkyl group. In a more preferred embodiment, R 3 It is difluoromethyl or trifluoromethyl.

[0033] Therefore, in a preferred embodiment of the present invention, the compound having formula (I) is a compound having formula (Ia):

[0034]

[0035] Where R 1 is hydrogen, fluorine, chlorine, bromine or CN, and R 2 , m and R 3 is as defined before.

[0036] In another preferred embodiment of the present invention, the compound having formula (I) is a compound having formula (Ib):

[0037]

[0038] Where R 1 is hydrogen, fluorine, chlorine, bromine or CN, and R 2 , m and R 3 is as defined before.

[0039] In another preferred embodiment of the present invention, the compound having formula (I) is a compound having formula (Ic):

[0040]

[0041] Where R1 is hydrogen, fluorine, chlorine, bromine or CN, and R 2 , m and R 3 is as defined before.

[0042] Compounds of formula (I) may contain asymmetric centers and may exist as single enantiomers, in pairs of enantiomers in any ratio, or, in the case of more than one asymmetric center, in all possible ratios of diastereomers. Typically, one of the enantiomers has an enhanced biological activity compared to the other possibilities.

[0043] The present invention also provides agriculturally acceptable salts of compounds of formula (I). Preferably, the compounds of formula (I) can form salts with amines including primary, secondary and tertiary amines (e.g. ammonia, dimethylamine and triethylamine), alkali metal bases and alkaline earth metal bases, transition metal bases or quaternary ammonium bases.

[0044] The compounds of formula (I) according to the invention can be used as herbicides themselves, but they are usually formulated into herbicidal compositions using formulation adjuvants such as carriers, solvents and surfactants (SAAs). Therefore, the present invention further provides a herbicidal composition comprising a herbicidal compound according to any one of the preceding claims and an agriculturally acceptable formulation adjuvant. The composition may be in the form of a concentrate, which is diluted before use, although ready-to-use compositions may also be prepared. The final dilution is usually carried out with water, but for example liquid fertilizers, micronutrients, biological organisms, oils or solvents may be used instead of or in addition to water.

[0045] The herbicidal compositions generally comprise from 0.1 to 99% by weight, in particular from 0.1 to 95% by weight, of a compound of formula I and from 1 to 99.9% by weight of formulation adjuvants, which preferably include from 0 to 25% by weight of surface-active substances.

[0046] The composition can be selected from a number of formulation types. These include emulsion concentrates (EC), suspension concentrates (SC), suspoemulsions (SE), capsule suspensions (CS), water dispersible granules (WG), emulsifiable granules (EG), water-in-oil emulsions (EO), oil-in-water emulsions (EW), microemulsions (ME), oil dispersions (OD), oil suspensions (OF), oil-soluble liquids (OL), soluble concentrates (SL), ultra-low volume suspensions (SU), ultra-low volume liquids (UL), parent drugs (TK), dispersible concentrates (DC), soluble powders (SP), wettable powders (WP) and soluble granules (SG). In any case, the formulation type selected will depend on the specific purpose envisioned and the physical, chemical and biological properties of the compound of formula (I).

[0047] Soluble powders (SP) can be prepared by mixing a compound of formula (I) with one or more water-soluble inorganic salts (such as sodium bicarbonate, sodium carbonate or magnesium sulfate) or one or more water-soluble organic solids (such as polysaccharides) and optionally one or more wetting agents, one or more dispersants or a mixture of said agents to improve water dispersibility / water solubility. The mixture is then ground into a fine powder. Similar compositions can also be granulated to form water-soluble granules (SG).

[0048] Wettable powders (WP) can be prepared by mixing a compound of formula (I) with one or more solid diluents or carriers, one or more wetting agents and preferably, one or more dispersants, and optionally, one or more suspending agents to facilitate dispersion in a liquid. The mixture is then ground into a fine powder. Similar compositions can also be granulated to form water dispersible granules (WG).

[0049] Granules (GR) may be formed by granulating a mixture of a compound of formula (I) and one or more powdered solid diluents or carriers, or by absorbing the compound of formula (I) (or a solution thereof in a suitable agent) into a porous granular material such as pumice, attapulgite clay, Fuller's earth, kieselguhr, diatomaceous earths or corn cob meal, or from preformed blank particles by adsorbing the compound of formula (I) (or a solution thereof in a suitable agent) onto a hard core material such as sand, silicates, mineral carbonates, sulfates or phosphates and, if necessary, drying. Agents commonly used to aid absorption or adsorption include solvents such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters and adhesives such as polyvinyl acetate, polyvinyl alcohol, dextrins, sugars and vegetable oils. One or more other additives may also be included in the granules (e.g., emulsifiers, wetting agents or dispersants).

[0050] Dispersible concentrates (DC) can be prepared by dissolving a compound of formula (I) in water or an organic solvent such as a ketone, alcohol or glycol ether. These solutions may contain a surfactant (for example to improve water dilution or to prevent crystallization in a spray tank).

[0051] Emulsifiable concentrates (EC) or oil-in-water emulsions (EW) can be prepared by dissolving a compound of formula (I) in an organic solvent (optionally containing one or more wetting agents, one or more emulsifiers or a mixture of said agents). Suitable organic solvents for use in ECs include aromatic hydrocarbons (such as alkylbenzenes or alkylnaphthalenes, for example SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; SOLVESSO is a registered trademark), ketones (such as cyclohexanone or methylcyclohexanone) and alcohols (such as benzyl alcohol, furfuryl alcohol or butanol), N-alkylpyrrolidones (such as N-methylpyrrolidone or N-octylpyrrolidone), dimethylamides of fatty acids (such as C8-C 10 EC products can spontaneously emulsify when added to water, producing an emulsion with sufficient stability to allow spray application by appropriate equipment.

[0052] The preparation of EWs involves obtaining a compound of formula (I) as a liquid (if it is not liquid at room temperature, it can be melted at a reasonable temperature, typically below 70°C) or in solution (by dissolving it in a suitable solvent), and then emulsifying the resulting liquid or solution into water containing one or more SAAs under high shear to produce an emulsion. Suitable solvents for use in EWs include vegetable oils, chlorinated hydrocarbons (such as chlorobenzene), aromatic solvents (such as alkylbenzenes or alkylnaphthalenes) and other suitable organic solvents having low solubility in water.

[0053] Microemulsions (MEs) can be prepared by mixing water with a blend of one or more solvents and one or more SAAs to spontaneously produce a thermodynamically stable, isotropic liquid formulation. The compound of formula (I) is initially present in water or in a solvent / SAA blend. Suitable solvents for use in MEs include those previously described for use in ECs or EWs. MEs can be oil-in-water systems or water-in-oil systems (which system is present can be determined by conductivity measurements) and can be suitable for mixing water-soluble and oil-soluble pesticides in the same formulation. MEs are suitable for dilution into water, remaining as a microemulsion or forming a conventional oil-in-water emulsion.

[0054] Suspension concentrates (SC) may include aqueous or non-aqueous suspensions of finely dispersed insoluble solid particles of a compound of formula (I). SC may be prepared by ball milling or bead milling a solid compound of formula (I) with one or more dispersants in a suitable medium to produce a fine particle suspension of the compound. One or more wetting agents may be included in the composition, and a suspending agent may be included to reduce the rate of particle settling. Alternatively, a compound of formula (I) may be dry-milled and added to water containing the reagents described hereinabove to produce a desired end product.

[0055] Aerosol formulations comprise a compound of formula (I) and a suitable propellant (e.g. n-butane). The compound of formula (I) may also be dissolved or dispersed in a suitable medium (e.g. water or a water-miscible liquid such as n-propanol) to provide a composition for use in a non-pressurized manual spray pump.

[0056] Capsule suspensions (CS) can be prepared in a similar manner to the preparation of EW formulations, but with an additional polymerization stage, so that an aqueous dispersion of oil droplets is obtained, wherein each oil droplet is wrapped by a polymer shell and contains a compound with formula (I) and optionally a carrier or diluent for the oil droplet. The polymer shell can be produced by an interfacial polycondensation reaction or by a coacervation procedure. These compositions can provide controlled release of compounds with formula (I) and they can be used for seed treatment. Compounds with formula (I) can also be formulated in a biodegradable polymer matrix to provide slow, controlled release of the compound.

[0057] The composition may contain one or more additives to improve the biological performance of the composition, for example by improving wettability, retention or distribution on a surface; rain resistance on the treated surface; or absorption or flow of the compound of formula (I). Such additives include surfactants (SAAs), oil-based spray additives, such as certain mineral oils or natural vegetable oils (such as soybean and rapeseed oils), modified vegetable oils (such as methylated rapeseed oil (MRSO)), and blends of these with other bioenhancing adjuvants (ingredients that can assist or modify the action of the compound of formula (I)).

[0058] The wetting agent, dispersant and emulsifier may be a cationic type, anionic type, amphoteric type or nonionic type SAA.

[0059] Suitable cationic-type SAAs include quaternary ammonium compounds (eg, cetyltrimethylammonium bromide), imidazolines, and amine salts.

[0060] Suitable anionic SAAs include alkali metal salts of fatty acids, salts of fatty sulfuric acid monoesters (e.g., sodium lauryl sulfate), salts of sulfonated aromatic compounds (e.g., sodium dodecylbenzenesulfonate, calcium dodecylbenzenesulfonate, butylnaphthalenesulfonate, and mixtures of sodium di-isopropyl-naphthalenesulfonate and sodium tri-isopropyl-naphthalenesulfonate), ether sulfates, alcohol ether sulfates (e.g., sodium laureth-3-sulfate), ether carboxylates (e.g., sodium laureth-3-carboxylate), phosphates (products from the reaction of one or more fatty alcohols with phosphoric acid (mainly monoesters) or with phosphorus pentoxide (mainly diesters), such as the reaction of lauryl alcohol with tetraphosphoric acid; these products may additionally be ethoxylated), sulfosuccinamates, paraffin or olefin sulfonates, taurates, lignosulfonates, and phosphates / sulfates of tristyrylphenol.

[0061] Suitable amphoteric types of SAA include betaine, propionate and glycinate.

[0062] Suitable SAAs of the nonionic type include condensation products of alkylene oxides (such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof) with fatty alcohols (such as oleyl alcohol or cetyl alcohol) or with alkylphenols (such as octylphenol, nonylphenol or octylcresol); partial esters derived from long-chain fatty acids or hexitol anhydrides; condensation products of the partial esters with ethylene oxide; block polymers (comprising ethylene oxide and propylene oxide); alkanolamides; monoesters (such as fatty acid polyethylene glycol esters); amine oxides (such as lauryl dimethyl amine oxide); lecithin and sorbitan and their esters, alkyl polyglycosides and tristyrylphenol.

[0063] Suitable suspending agents include hydrophilic colloids (such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose) and swelling clays (such as bentonite or attapulgite).

[0064] The herbicidal compounds of the present invention can also be used in mixtures with one or more additional herbicides and / or plant growth regulators. Examples of such additional herbicides or plant growth regulators include acetochlor, acifluorfen (including acifluorfen sodium), bennitroprop-butyl, ametryn, amitriptyline, aminopyralid, cypermethrin, atrazine, benzylsulfuron-methyl (including benzylsulfuron-methyl), bentazon, bicyclpyrone, bialaphos, bispyribac-sodium, bixlozone, herbicide, bromoxynil, butachlor, fluazifop-butyl, mesotrione (including mesotrione-ethyl), chlorsulfuron (including chlorsulfuron-methyl), chlorsulfuron (including chlorsulfuron-ethyl), chlorotoluron, chlorsulfuron, cyproconazole, clacyfos, clethodim, clodinafop-butyl (including clodinafop-butyl), isothiocarb, dichloro Pyridine acid, cyclopyranil, cyclopyrimorate, cyprosulfuron, cyhalofop-butyl (including cyhalofop-butyl-butyl), 2,4-D (including its choline salt and 2-ethylhexyl ester), 2,4-DB, dichlorvos, dicamba (including its aluminum, aminopropyl, bis-aminopropylmethyl, choline, dichloropropane, diglycolamine, dimethylamine, dimethylammonium, potassium and sodium salts), bisclostrobin, fluazifop-butyl, fluazifop-butyl, dimethoate, dimethoate-s-propyl, diquat, diuron, ethosulfuron, oxadiazine (including oxadiazine-ethyl), fenoxasulfone e), fenquinotrione, tetrazopyramide, fluazifop-butyl, bispyribac, florpyrauxifen (including florpyrauxifen-benzyl), fluazifop-butyl (including fluazifop-butyl-butyl), fluazifop-butyl (including fluazifop-butyl-sodium), flufenacet, fluazifop-butyl, fluazifop-butyl (including fluazifop-methyl-sodium), fluroxypyr (including fluroxypyr-meptyl), flufenacet-butyl, foramsulfuron, glufosinate (including its ammonium salt), glyphosate (including its hydrazine, isopropyl ammonium and potassium salt), halauxifen (including fluazifop-methyl), fluazifop-methyl (including fluazifop-methyl), hexazinone, hydantocidin, imazamox, imazamox, imazamox, indazine fluazifop-methyl, iodosulfuron (including iodosulfuron-methyl-sodium), iofensulfuron (including iofensulfuron-sodium), iobenzonitrile, isoproturon, isoxathiapiprolon, lancotrione, MCPA, MCPB, mecoprop-P, mesosulfuron (including mesosulfuron-methyl), mesotrione, metamitron, metazachlor, methiozolin, isopropylamine,Sulfonamide, metribuzin, metsulfuron-methyl, propamide, nicosulfuron, norfad, oxadiazine, oxazolidinone, oxyfluorfen, paraquat dichloride, pendimethalin, penoxsulam, bendiquat, picloram, pinoxaden, pretilachlor, primisulfuron-methyl, propanil, cypermethrin, propyrisulfuron, propyrisulfuron, promethazine, prosulfuron, bispyribac, pyraflufen (including pyraflufen-ethyl), pyrasulfuron, pyridasulfuron, pyrimidin, pyrimisulfan, pyroxasulfone, pyridinesulfuron, quinclorac, clomeclorac, quizalofop-ethyl (including quinazolin-ethyl) quinoxaline-ethyl and quizalofop-P-tefuryl), sulfamethoxam, pyrimidine oxime, sethoxydim, simazine, S-isopropylamine, sulfentrazone, sulfentrazone, sulfentrazone, buthiuron, tefuridine, tetradione, tetradione, terbuthion, terbutaline, thiencarbazone, thifensulfuron, tiafenacil, tolpyralate, benpyrazone, trimethoprim-butyl, triafamone, wild wheat chlorpyrifos, ether bensulfuron-methyl, bensulfuron-methyl (including bensulfuron-methyl), triclopyr, trifloxysulfuron (including trifloxysulfuron-sodium), trifluoperazine (including trifloxysulfuron-methyl), ... imoxazin), fluralin, flufensulfuron, 4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolin-2-one, 4-hydroxy-1,5-dimethyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolin-2-one, 5-ethoxy-4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolin-2-one, 4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolin-2-one, 4-hydroxy-1,5-dimethyl-3-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]imidazolin-2-one, (4R)1-(5-tert-butylisoxazole-3 -yl)-4-ethoxy-5-hydroxy-3-methyl-imidazolin-2-one, 3-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]bicyclo[3.2.1]octane-2,4-dione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-5-methyl-cyclohexane-1,3-dione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]cyclohexane-1,3-dione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-5,5-dimethyl-cyclohexane-1,3-dione,6-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-2,2,4,4-tetramethyl-cyclohexane-1,3,5-trione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-5-ethyl-cyclohexane-1,3-dione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-5-ethyl-cyclohexane-1,3-dione 2-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]-5-methyl-cyclohexane-1,3-dione, 3-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]bicyclo[3.2.1]octane-2,4-dione, 2-[ 6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]-5,5-dimethyl-cyclohexane-1,3-dione, 6-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]-2,2,4,4-tetramethyl-cyclohexane-1,3,5-trione, 2-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]-5,5-dimethyl-cyclohexane-1,3-dione 4-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-2,2,6,6-tetramethyl-tetrahydropyran-3,5-dione and 4-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]-2,2,6,6-tetramethyl-tetrahydropyran-3,5-dione.

[0065] Mixtures of compounds of formula (I) may also be in the form of esters or salts, as mentioned, for example, in The Pesticide Manual, Sixteenth Edition, British Crop Protection Council, 2012.

[0066] The compounds of formula (I) can also be used in a mixture with other agrochemicals such as fungicides, nematicides or insecticides, examples of which are given in The Pesticide Manual.

[0067] The mixing ratio of the compound of formula (I) to the mixing partner is preferably from 1:100 to 1000:1.

[0068] These mixtures can advantageously be used in the abovementioned formulations ("active ingredient" in this case relates to the corresponding mixture of the compound of formula (I) with the mixing partner).

[0069] Compounds or mixtures of the present invention can also be used in combination with one or more herbicide safeners. Examples of such safeners include fenthiocarb, cloquintocet-mexyl (including cloquintocet-mexyl), cyclopropylsulfonamide, dichloropropene, fenthiocarb (including fenthiocarb-ethyl), fenthiocarb, fluazifop, fenthiocarb, isoxadiazole (including isoxadiazole-ethyl), mefenpyr (including pyrazoles oxalic acid-diethyl), metcamifen and oxalonitrile.

[0070] Particularly preferred are mixtures of compounds of formula (I) with ciprosulfamide, isoxadifen-ethyl, clofonethiol and / or N-(2-methoxybenzoyl)-4-[(methyl-aminocarbonyl)amino]benzenesulfonamide.

[0071] The safeners of compounds of formula (I) may also be in the form of esters or salts, as mentioned, for example, in The Pesticide Manual, 16th edition (BCPC), 2012. References to clofonethiol also apply to its lithium, sodium, potassium, calcium, magnesium, aluminum, iron, ammonium, quaternary ammonium, sulfonium or phosphonium salts (as disclosed in WO 02 / 34048).

[0072] Preferably, the mixing ratio of compound of formula (I) to safener is from 100:1 to 1:10, in particular from 20:1 to 1:1.

[0073] The present invention further provides a method for controlling weeds in a place, the method comprising applying a composition comprising a compound of formula (I) to the place in a controlled amount of weeds. In addition, the present invention may further provide a method for selectively controlling weeds at a place including crop plants and weeds, wherein the method comprises applying a composition according to the present invention to the place in a controlled amount of weeds. 'Control' means killing, reducing or delaying growth or preventing or reducing germination. It should be noted that the compounds of the present invention show greatly improved selectivity compared to known structurally similar compounds. Plants to be controlled are usually unwanted plants (weeds). 'Place' means the area where the plant is growing or will grow. Application can be applied to the place before and / or after the emergence of the crop plant. Some crop plants can inherently tolerate the herbicidal effect of the compound of formula (I). Preferred crop plants include corn, wheat, barley and rice.

[0074] The application rate of the compound of formula I can vary within a wide range and depends on the nature of the soil, the method of application (pre-emergence or post-emergence; seed dressing; application to the seed furrow; no-till application, etc.), the crop plants, one or more weeds to be controlled, the prevailing climatic conditions, and other factors governed by the method of application, the time of application, and the target crop. The compound of formula I according to the invention is usually applied at a rate of from 10 to 2500 g / ha, in particular from 25 to 1000 g / ha, more particularly from 25 to 250 g / ha.

[0075] Application is usually made by spraying the composition, typically by means of a tractor-mounted sprayer for large areas, but other methods such as dusting (for powders), dripping or drenching may also be used.

[0076] Crop plants are to be understood as also including those crop plants which have been rendered tolerant to other herbicides or classes of herbicides (e.g. ALS-inhibitors, GS-inhibitors, EPSPS-inhibitors, PPO-inhibitors, HPPD-inhibitors, inhibitor-PDS and ACCase-inhibitors) by conventional methods of breeding or by genetic engineering. Examples of crops which have been rendered tolerant to imidazolinones (e.g. imazamox) by conventional methods of breeding are Summer rapeseed (canola). Examples of crops that have been rendered resistant to herbicides by genetic engineering methods include, for example, glyphosate- and glufosinate-resistant maize varieties sold under the trade names Roundup and The following are commercially available.

[0077] Crop plants are also to be understood as those crops which have been rendered resistant to harmful insects by genetic engineering methods, for example Bt maize (resistant to the European corn borer), Bt cotton (resistant to the boll weevil) and also Bt potato (resistant to the Colorado beetle). Examples of Bt maize are Bt 176 corn hybrid (Syngenta Seeds). Bt toxins are proteins naturally produced by the soil bacterium Bacillus thuringiensis. Examples of toxins or transgenic plants capable of synthesizing such toxins are described in EP-A-451 878, EP-A-374 753, WO 93 / 07278, WO 95 / 34656, WO 03 / 052073 and EP-A-427 529. Examples of transgenic plants comprising one or more genes encoding insecticide resistance and expressing one or more toxins are (Corn), Yield (corn), (cotton), (cotton), (potato), as well as Plant crops or their seed material can be both herbicide resistant and simultaneously resistant to insect feeding ("stacked" transgenic results). For example, seeds can have the ability to express an insecticidal Cry3 protein while being resistant to glyphosate.

[0078] Crop plants are also to be understood as including those which are obtained by conventional methods of breeding or genetic engineering and contain so-called output traits (for example improved storage stability, higher nutritional value and improved aroma).

[0079] These compositions can be used to control unwanted vegetation (collectively referred to as 'weeds'). The weeds to be controlled can be both monocotyledonous species such as bentgrass, alopecurus, avena, brachiaria, brome, tricholoma, sedge, crabgrass, barnyard grass, sedge, ryegrass, perennial ryegrass, sedge, cyperus, sagittaria, scabrous grass, setaria and sorghum, and dicotyledonous species such as abutilon, amaranth, ragweed, quinoa, chrysanthemum, sedum, elaeagnus, ivy, ipomoea, nasturtium, spatholobus, sinapis, solanum, chickweed, veronica, violet and xanthium.

[0080] In a further aspect of the invention there is provided the use of a compound of formula (I) as defined herein as a herbicide.

[0081] The compounds of the present invention can be prepared according to the following schemes.

[0082] Process for preparing compounds having formula (I)

[0083] Processes for preparing compounds such as compounds of formula (I) (which optionally may be agrochemically acceptable salts thereof) are now described and form a further aspect of the invention.

[0084]

[0085] Compounds of formula I can be prepared by reacting compounds of formula A with compounds of formula B (wherein LG represents a suitable leaving group, such as Br, Cl, F or OSO2Me), optionally in the presence of a suitable base and in a suitable solvent at a suitable reaction temperature. Suitable bases may include K2CO3 or Cs2CO3. Suitable solvents include DMF. Suitable reaction temperatures are between 20°C and 120°C. Compounds of formula B are commercially available or can be prepared by methods known in the literature.

[0086]

[0087] Alternatively, compounds of formula A can be prepared from compounds of formula C (wherein PG represents a suitable protecting group such as Me or Ac) via a deprotection reaction. When PG = Me, suitable deprotection conditions include the use of BBr in a suitable solvent such as DCM. When PG = Ac, suitable deprotection conditions include the use of KCO or NH4OAC in a suitable solvent such as MeOH or MeOH / H2O.

[0088]

[0089] Compounds of formula C can be prepared by reacting compounds of formula D (wherein X represents a suitable halogen (such as F, Cl, Br or I) or a suitable pseudohalogen (such as OTf)) with compounds of formula E (wherein Y represents a suitable coupling partner functional group, such as -B(OR)2 or -SnR3) in the presence of a suitable catalyst / ligand combination, optionally in the presence of a suitable base and in a suitable solvent. Suitable catalysts may include bis-triphenylphosphine-palladium chloride (II). Suitable bases may include Cs2CO3. Suitable solvents may include 1,4-dioxane or DMF. Compounds of formula D and formula E are commercially available or may be prepared by methods known in the literature.

[0090]

[0091] In an alternative approach, a compound of formula C can be prepared from a compound of formula F (wherein Y represents a suitable coupling partner functional group, such as -B(OR)2 or -SnR3) and a compound of formula G (wherein Q is a C-attached heterocycle (such as Q1 and Q2), and wherein X represents a suitable halogen (such as F, Cl, Br or I) or a suitable pseudohalogen (such as OTf)) in the presence of a suitable catalyst / ligand combination, optionally in the presence of a suitable base and in a suitable solvent. Suitable catalysts may include tetrakis(triphenylphosphine)palladium. Suitable bases may include K2CO3. Suitable solvents may include DCM / H2O. Compounds of formula F and of formula G are commercially available or may be prepared by methods known in the literature.

[0092]

[0093] In an alternative approach, a compound of formula I can be prepared from a compound of formula H, wherein X represents a suitable halogen (such as F, Cl, Br or I) or a suitable pseudohalogen (such as OTf) and a compound of formula E, wherein Y represents a suitable coupling partner functional group, such as -B(OR)2 or -SnR3, in the presence of a suitable catalyst / ligand combination, optionally in the presence of a suitable base and in a suitable solvent. Suitable catalysts may include bis-triphenylphosphine-palladium chloride (II). Suitable bases may include Cs2CO3. Suitable solvents may include 1,4-dioxane or DMF. Compounds of formula E are commercially available or may be prepared by methods known in the literature.

[0094]

[0095] Compounds of formula H can be prepared by compounds of formula J and compounds of formula B (wherein LG represents a suitable leaving group, such as Br, Cl, F or OSO2Me) in the presence of a suitable base and in a suitable solvent. Suitable bases can include Cs2CO3, K2CO3 or NaH. Suitable solvents can include DMF or DMSO. Compounds of formula J and formula B are commercially available or can be prepared by methods known in the literature.

[0096]

[0097] In another alternative method, a compound of formula I can be prepared by a compound of formula K (wherein Y represents a suitable coupling partner functional group, such as -B(OR)2 or -SnR3) and a compound of formula G (wherein Q is a C-attached heterocycle, and wherein X represents a suitable halogen (such as F, Cl, Br or I) or a suitable pseudohalogen (such as OTf)) in the presence of a suitable catalyst / ligand combination, optionally in the presence of a suitable base and in a suitable solvent. Suitable catalysts may include tetrakis(triphenylphosphine)palladium. Suitable bases may include K2CO3. Suitable solvents may include DCM / H2O. Compounds of formula G are commercially available or may be prepared by methods known in the literature.

[0098]

[0099] Compounds of formula K can be prepared by compounds of formula L (wherein Y represents a suitable coupling partner functional group, such as -B(OR)2 or -SnR3) and compounds of formula B (wherein LG represents a suitable leaving group, such as Br, Cl, F or OSO2Me) in the presence of a suitable base and in a suitable solvent. Suitable bases can include Cs2CO3, K2CO3 or NaH. Suitable solvents can include DMF or DMSO. Compounds of formula L and formula B are commercially available or can be prepared by methods known in the literature.

[0100]

[0101] In yet another alternative method, a compound of formula I can be prepared by a compound of formula M (wherein X represents a suitable halogen (such as F, Cl, Br or I) or a suitable pseudohalogen (such as OTf)) and a compound of formula N in the presence of a suitable catalyst, optionally in the presence of a suitable base and in a suitable solvent. Suitable catalysts may include copper iodide (I). Suitable bases may include K2CO3. Suitable solvents may include DMSO. Compounds of formula M and formula N are commercially available or may be prepared by methods known in the literature.

[0102]

[0103] In yet another alternative, compounds of formula C may be prepared from compounds of formula P (wherein J is an alkene, alkyne, oxime, ketone, carboxylic acid, ester, amide, hydrazine, azide or amine) using methods of heterocycle formation known in the literature.

[0104]

[0105] Similarly, compounds of formula I can be prepared from compounds of formula Q (wherein J is an alkene, alkyne, oxime, ketone, carboxylic acid, ester, amide, hydrazine, azide or amine) using heterocycle formation methods known in the literature.

[0106]

[0107] In another method, a compound of formula Ci (a compound of formula C, wherein Q is a suitable ortho-directing heterocycle, such as Q9, Q11, Q12, Q34 or Q35) can be prepared by a compound of formula R in the presence of a suitable catalyst, a suitable oxidant and a suitable nucleophilic agent. Suitable catalysts may include Pd(OAc)2. Suitable oxidants may include (diacetoxyiodo)benzene. Suitable nucleophilic agents may include acetic acid.

[0108]

[0109] Compounds of formula R can be prepared by reacting compounds of formula S (wherein X represents a suitable halogen (such as Cl, Br or I) or a suitable pseudohalogen (such as OTf)) with compounds of formula E (wherein Y represents a suitable coupling partner functional group, such as -B(OR)2 or -SnR3) in the presence of a suitable catalyst / ligand combination, optionally in the presence of a suitable base and in a suitable solvent. Suitable catalysts can include bis-triphenylphosphine-palladium chloride (II). Suitable bases can include Cs2CO3. Suitable solvents can include 1,4-dioxane or DMF. Compounds of formula S and E are commercially available or can be prepared by methods known in the literature.

[0110]

[0111] Alternatively, a compound of formula R can be prepared by a compound of formula T (wherein Y represents a suitable coupling partner functional group, such as -B(OR)2 or -SnR3) and a compound of formula G (wherein Q is a C-connected heterocycle, and wherein X represents a suitable halogen (such as F, Cl, Br or I) or a suitable pseudohalogen (such as OTf)) in the presence of a suitable catalyst / ligand combination, optionally in the presence of a suitable base and in a suitable solvent. Suitable catalysts may include tetrakis(triphenylphosphine)palladium. Suitable bases may include K2CO3. Suitable solvents may include DCM / H2O. Compounds of formula T and of formula G are commercially available or may be prepared by methods known in the literature.

[0112]

[0113] In an alternative method, a compound of formula Cii (a compound of formula C wherein R 1-邻位 = halogen, and Q is a suitable ortho-positioned heterocycle, such as Q9, Q11, Q12, Q34 or Q35) can be prepared from compounds of formula Ciii (compounds of formula C, wherein R 1-邻位 =H) is prepared via reaction with a suitable halogenating agent in the presence of a suitable catalyst and optionally in a suitable solvent. Suitable halogenating agents may include N-iodosuccinimide, N-bromosuccinimide, N-chlorosuccinimide or N-fluorobenzenesulfonimide. Suitable catalysts may include Pd(OAc)2. Suitable solvents may include acetic acid.

[0114]

[0115] In yet another alternative method, a compound of formula A (wherein Q is an N-linked heterocycle and R 1 is an electron withdrawing group such as halogen, CN or NO2) can be prepared from a compound of formula U by reacting with a compound of formula V in the presence of a suitable base and in a suitable solvent. N Ar reaction. Suitable bases may include K2CO3. Suitable solvents may include N,N-dimethylacetamide. Compounds of formula U and formula V are commercially available or may be prepared by methods known in the literature.

[0116] The following non-limiting examples provide specific synthetic methods for representative compounds of the present invention (as mentioned in Table 1 below).

[0117] Example 1: Synthesis of 5-[2-[(5-chloro-3-fluoro-2-pyridyl)oxy]-6-fluoro-phenyl]-3-(difluoromethyl)isoxazole (A1)

[0118]

[0119] To a stirred solution of 2-[3-(difluoromethyl)isoxazol-5-yl]-3-fluoro-phenol (0.06 g, 0.26 mmol) in N-dimethylformamide (1.8 mL) was added K2CO3 (0.18 g, 1.3 mmol), followed by 5-chloro-2,3-difluoro-pyridine (0.049 g, 0.33 mmol). The reaction was stirred at room temperature overnight and then heated to 80 ° C for 4 hours. The reaction mixture was cooled to room temperature, diluted with DCM and acidified with 2M HCl, the phases were separated, the aqueous phase was then re-extracted with DCM, and the combined organics were evaporated to dryness under reduced pressure. The crude residue was purified by flash chromatography on silica gel using a gradient of 0%-10% of ethyl acetate in isohexane as eluent to give the desired product (0.066 g, 70%) as a white solid.

[0120] 1 H NMR(400MHz, CDCl3)δ7.83(d,1H),7.57(d,2H),7.24-7.08(m,2H),6.94-6.61(m,2H)

[0121] Example 2: Synthesis of 3-(difluoromethyl)-5-[2-fluoro-6-[(5-nitro-2-pyridyl)oxy]phenyl]isoxazole (A2)

[0122]

[0123] To a stirred solution of 2-[3-(difluoromethyl)isoxazol-5-yl]-3-fluoro-phenol (0.06 g, 0.26 mmol) in N,N-dimethylformamide (1.8 mL) was added KCO (0.18 g, 1.3 mmol) followed by 2-chloro-5-nitro-pyridine (0.052 g, 0.33 mmol). The reaction was stirred overnight at room temperature then diluted with DCM and acidified with 2M HCl, the phases separated then the aqueous phase was re-extracted with DCM and the combined organics evaporated to dryness under reduced pressure. The crude residue was purified by flash chromatography on silica gel using a gradient of 0%-20% of ethyl acetate in isohexane as eluent to give the desired product (0.078 g, 85%) as a colorless oil.

[0124] 1 H NMR(400MHz, CDCl3)δ8.95(d,1H),8.64-8.43(m,1H),7.59(dt,1H),7.32-7.10(m,3H),6.97-6.53(m,2H)

[0125] Example 3: Synthesis of 2-[2-[(5-chloro-3-fluoro-2-pyridyl)oxy]-6-fluoro-phenyl]-5-(trifluoromethyl)oxazole (A3)

[0126]

[0127] To a stirred solution of 3-(2-fluoro-6-hydroxy-phenyl)-5-(trifluoromethyl)-4H-isoxazol-5-ol (0.100 g, 0.377 mmol) in DMF (5 mL) was added KCO (0.317 g, 2.26 mmol) and 5-chloro-2,3-difluoropyridine (0.141 g, 0.943 mmol). The reaction was heated at 80 °C for 4 hours and then allowed to cool to room temperature. The reaction mixture was diluted with EtOAc and H0, the phases were separated and the aqueous phase was extracted with additional EtOAc. The combined organics were washed with H0, dried over MgSO4 and evaporated to dryness under reduced pressure. The crude residue was purified by flash chromatography on silica gel using 0%-10% EtOAc / isohexane as eluent to give the desired product (0.068 g, 48%) as a pale yellow solid.

[0128] 1 H NMR (400MHz, CDCl3) δ7.78(d,1H),7.67-7.42(m,3H),7.24-7.05(m,2H).

[0129] Example 4: Synthesis of 5-nitro-2-[2-[4-(trifluoromethyl)pyrazol-1-yl]phenoxy]pyridine (A14)

[0130] Step 1: Synthesis of 1-(2-methoxyphenyl)-4-(trifluoromethyl)pyrazole

[0131]

[0132] To a stirred solution of 1-bromo-2-methoxy-benzene (0.20 g, 1.07 mmol) in 1,4-dioxane (4 mL) was added 4-(trifluoromethyl)-1H-pyrazole (0.291 g, 2.14 mmol), CuI (0.204 g, 1.07 mmol), N,N'-dimethylethane-1,2-diamine (0.189 mg, 2.74 mmol) and K2CO3 (0.227 g, 1.64 mmol). The reaction was heated at reflux for 72 hours, allowed to cool to room temperature, adsorbed onto silica gel and purified by flash chromatography on silica gel using a gradient of 5%-50% EtOAc in isohexane as eluent to give the desired product (0.169 g, 65%) as a colorless oil.

[0133] 1 H NMR (400MHz, CDCl3) δ8.31(s,1H),7.88(s,1H),7.72(d,1H),7.36(t,1H),7.11-7.03(m,2H),3.91(s,3H).

[0134] Step 2: Synthesis of 2-[4-(trifluoromethyl)pyrazol-1-yl]phenol

[0135]

[0136] To a stirred solution of 1-(2-methoxyphenyl)-4-(trifluoromethyl)pyrazole (1.25 g, 5.16 mmol) in DCM (100 mL) was added BBr (12.9 mL of a 1 M solution in DCM, 12.9 mmol) at 0°C under N2 atmosphere. The reaction mixture was allowed to warm to 15°C over 2 hours, quenched with water, the pH adjusted to 7 with saturated NaHCO3 solution and extracted with DCM (×3). The combined organic extracts were washed with brine, dried over MgSO4, adsorbed on silica gel and purified by flash chromatography on silica gel using a gradient of 5%-50% EtOAc in isohexane as eluent to give the desired product (1.06 g, 90%) as a white solid.

[0137] 1H NMR (400MHz, CDCl3) δ10.50(s,1H),8.28(s,1H),7.94(s,1H),7.39(d,1H),7.26(t,1H),7.12(d,1H),6.96(t,1H).

[0138] Step 3: Synthesis of 5-nitro-2-[2-[4-(trifluoromethyl)pyrazol-1-yl]phenoxy]pyridine (A14)

[0139]

[0140] To a stirred solution of 2-[4-(trifluoromethyl)pyrazol-1-yl]phenol (0.20 g, 0.88 mmol) in DMF (5 mL) was added KCO (0.242 g, 1.75 mmol) and 2-chloro-5-nitro-pyridine (0.166 mg, 1.05 mmol). The reaction was heated at 80 °C for 3 hours, allowed to cool to room temperature, washed with H0 and extracted with Et0 (x3). The combined organic extracts were washed with brine, dried over MgSO and evaporated to dryness under reduced pressure to give a brown solid. The crude product was purified by flash chromatography on silica gel using a gradient of 5%-50% EtOAc in isohexane as eluent to give the desired product (0.078 g, 26%) as a pale yellow solid.

[0141] 1 H NMR (400MHz, CDCl3) δ8.91(s,1H),8.45(dd,1H),8.02(s,1H),7.79-7.70(m,2H),7.55-7.49(m,1H),7.49-7.42(m,1H),7.32(d,1H),7.03(d,1H)

[0142] Example 5: Synthesis of 5-chloro-2-[2-(4-chloropyrazol-1-yl)phenoxy]-3-fluoro-pyridine (A24)

[0143] Step 1: Synthesis of 5-chloro-3-fluoro-2-(2-iodophenoxy)pyridine

[0144]

[0145] To a stirred solution of 2-iodophenol (6.40 g, 29.1 mmol) in DMF (64 mL) was added KCO (8.04 g, 58.2 mmol) and 5-chloro, 2,3-difluoropyridine (5.22 g, 34.9 mmol) and the reaction was heated at 80 ° C for 16 hours. The reaction was cooled to room temperature, diluted with H O (200 mL) and extracted with Et O (3×75 mL). The combined organic extracts were washed with brine, dried over MgSO and evaporated to dryness under reduced pressure to give a yellow oil. The crude product was purified by flash chromatography on silica gel using a gradient of 5%-50% EtOAc in cyclohexane to give the desired product (10.10 g, 99%) as a colorless oil.

[0146] 1 H NMR (400MHz, CDCl3) δ7.91-7.82(m,2H),7.53(dd,1H),7.41(t,1H),7.18(d,1H),7.01(t,1H)

[0147] Step 2: Synthesis of 5-chloro-2-[2-(4-chloropyrazol-1-yl)phenoxy]-3-fluoro-pyridine (A24)

[0148]

[0149] To a stirred solution of 5-chloro-3-fluoro-2-(2-iodophenoxy)pyridine (0.20 g, 0.572 mmol) in 1,4-dioxane (4 mL) was added 4-chloro-1H-pyrazole (0.117 mg, 1.14 mmol), CuI (0.109 g, 0.572 mmol), N,N'-dimethylethane-1,2-diamine (0.108 g, 1.14 mmol) and K2CO3 (0.168 g, 1.22 mmol) and the reaction was heated at reflux for 16 hours. The reaction was cooled to room temperature, diluted with H2O (10 mL) and extracted with EtOAc (3×15 mL). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure to give a brown oil. The crude product was purified by flash chromatography on silica gel using a gradient of EtOAc in cyclohexane 5%-50% as eluent to give the desired product (27 mg, 14%) as a white solid.

[0150] 1 H NMR (400MHz, CDCl3) δ7.81(s,1H),7.72(d,1H),7.69(dd,1H),7.48(s,1H),7.42(dd,1H),7.37-7.28(m,2H),7.19(dd,1H).

[0151] Example 6: Synthesis of 3-[2-[(5-chloro-3-fluoro-2-pyridyl)oxy]-6-fluoro-phenyl]-5-(trifluoromethyl)isoxazole (A25)

[0152] Step 1: Synthesis of 3-fluoro-2-[5-(trifluoromethyl)isoxazol-3-yl]phenol

[0153]

[0154] To a stirred solution of 3-(2-fluoro-6-hydroxy-phenyl)-5-(trifluoromethyl)-4H-isoxazole-5-ol (20.0 g, 75.4 mmol) in toluene (150 mL) was added p-toluenesulfonic acid monohydrate (1.59 g, 9.05 mmol). The reaction was heated at reflux for 2 h with azeotropic removal of water, then cooled to room temperature and evaporated to dryness under reduced pressure. The residue was dissolved in CH2Cl2 (500 ml) and gradually added to a stirred solution of saturated NaHCO3 aqueous solution (200 ml). The organic phase was separated and washed with H2O then with brine and evaporated to dryness under reduced pressure to leave the desired product (17.41 g, 93%) as an off-white solid, which was used without further purification.

[0155] 1 H NMR (400MHz, CDCl3) δ9.54(s,1H),7.35(m,2H),6.94(d,1H),6.76(t,1H).

[0156] Step 2: Synthesis of 3-[2-[(5-chloro-3-fluoro-2-pyridyl)oxy]-6-fluoro-phenyl]-5-(trifluoromethyl)isoxazole (A25)

[0157]

[0158] 5-Chloro-2,3-difluoro-pyridine (3.03 g, 20.2 mmol) and potassium carbonate (0.85 g, 6.07 mmol) were added to a solution of 3-fluoro-2-[5-(trifluoromethyl)isoxazol-3-yl]phenol (1.00 g, 4.05 mmol) in N,N-dimethylformamide (15 mL). The reaction was heated at 80 ° C for 3.5 hours, cooled to room temperature, and then quenched by adding H2O. The reaction was then extracted with EtOAc (× 3), and the combined organic extracts were washed with H2O and brine, then dried over MgSO4, and evaporated to dryness under reduced pressure to leave a yellow oil. The crude product was purified by flash chromatography on silica gel using a gradient of 100% cyclohexane to 10% EtOAc / cyclohexane as eluent to give the desired product (30 mg, 2%) as a light yellow gum.

[0159] 1 H NMR(400MHz, CDCl3)δ7.81(s,1H),7.54(m,2H),7.15(t,1H),7.10(d,1H),6.99(s,1H)

[0160] Example 7: Synthesis of 5-chloro-3-fluoro-2-(2-imidazol-1-ylphenoxy)pyridine (A28)

[0161] Step 1: Synthesis of 1-(2-methoxyphenyl)imidazole

[0162]

[0163] A mixture of imidazole (0.806 g, 0.012 mol), (2-methoxyphenyl) boronic acid (1.50 g, 0.0099 mol) and Cu(I)Cl (0.100 g, 0.001 mol) in MeOH (50 mL) was heated overnight under reflux. The reaction mixture was cooled to room temperature and evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography on silica gel using a gradient of MeOH / DCM 0%-5% as eluent to give the desired product (133 mg, 7%) as a brown oil.

[0164] 1 H NMR(400MHz, CDCl3)δ7.79(s,1H),7.34(t,1H),7.28(d,1H),7.20(s,1H),7.16(s,1H),7.09-7.00(m,2H),3.84(s,3H)

[0165] Step 2: Synthesis of 2-imidazol-1-ylphenol

[0166]

[0167] At 0 ° C under nitrogen, boron tribromide (1M solution in DCM) (2.22 mL, 2.22 mmol) was added dropwise to a solution of 1- (2-methoxyphenyl) imidazole (55 mg, 0.89 mmol) in dichloromethane (18 mL), and the temperature was maintained at <5 ° C. Once the addition was completed, the reaction mixture was stirred at this temperature for 1 hour, and then allowed to warm to room temperature and stirred at room temperature for 72 hours. The reaction mixture was quenched with water and adjusted to pH 7 with saturated sodium bicarbonate aqueous solution, then washed with DCM (× 3). An off-white solid was precipitated from the aqueous layer. The solid was filtered out, washed with a small amount of water and dried in a vacuum oven at 40 ° C for 3 hours to give the desired product (133 mg, 93%) as a beige solid.

[0168] 1 H NMR (400MHz, CD3OD)δ=7.92(s,1H),7.38(s,1H),7.30(d,1H),7.22(t,1H),7.09(s,1H),7.01(d,1H),6.93(t,1H)

[0169] Step 3: Synthesis of 5-chloro-3-fluoro-2-(2-imidazol-1-ylphenoxy)pyridine (A28)

[0170]

[0171] A mixture of 5-chloro-2,3-difluoro-pyridine (0.149 g, 0.10 mmol), 2-imidazole-1-ylphenol (0.133 g, 0.83 mmol) and K2CO3 (0.230 g, 1.66 mmol) in DMF (5 mL) was heated at 90 ° C overnight. The reaction mixture was cooled to room temperature, diluted with water and extracted with EtOAc (× 3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography on silica gel using a gradient of 0%-5% of MeOH in DCM as eluent to give the desired product (0.226 g, 94%) as a yellow oil.

[0172] 1 H NMR(400MHz, CDCl3)δ7.71(s,1H),7.68(s,1H),7.51-7.34(m,4H),7.31(d,1H),7.14(s,1H),7.03(s,1H)

[0173] Example 8: Synthesis of 3-[(5-chloro-3-fluoro-2-pyridyl)oxy]-2-[4-(trifluoromethyl)pyrazol-1-yl]benzonitrile (A33)

[0174] Step 1: Synthesis of 3-hydroxy-2-[4-(trifluoromethyl)pyrazol-1-yl]benzonitrile

[0175]

[0176] Under nitrogen atmosphere, powdered K2CO3 (3.1 g, 22 mmol) was added to a solution of 2-fluoro-3-hydroxy-benzonitrile (1.0 g, 7.3 mmol) and 4-(trifluoromethyl)-1H-pyrazole (1.1 g, 8.0 mmol) in N,N-dimethylacetamide (15 mL). The resulting mixture was heated at 150 ° C for 22 hours. The reaction mixture was cooled to room temperature, diluted with water and extracted with EtOAc (× 4). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness to give an orange liquid. The crude product was purified by flash chromatography on silica gel using a gradient of 20% to 40% of EtOAc in cyclohexane as an eluent to give the desired product (594 mg, 32%) as a yellow solid.

[0177] 1 H NMR (400MHz, CDCl3) δ = 8.64 (s, 1H), 8.07 (s, 1H), 7.42-7.35 (m, 3H).

[0178] Step 2: Synthesis of 3-[(5-chloro-3-fluoro-2-pyridyl)oxy]-2-[4-(trifluoromethyl)pyrazol-1-yl]benzonitrile (A33)

[0179]

[0180] To a solution of 3-hydroxy-2-[4-(trifluoromethyl)pyrazol-1-yl]benzonitrile (0.180 g, 0.711 mmol) and 5-chloro-2,3-difluoro-pyridine (0.138 g, 0.924 mmol) in N,N-dimethylformamide (4.50 mL) was added K2CO3 (0.248 g, 1.78 mmol). The mixture was heated at 130 ° C for 1 hour under microwave irradiation. The reaction mixture was poured into water and extracted with EtOAc (× 3). The combined organic extracts were washed with 1M NaOH solution and then with brine, dried over MgSO4 and evaporated to dryness under reduced pressure to give a brown liquid. The crude product was purified by flash chromatography on silica gel using a gradient of 0% to 50% of EtOAc in cyclohexane as an eluent to give the desired product (0.191 g, 63%) as a white solid.

[0181] 1H NMR (400MHz, CDCl3) δ = 8.03 (s, 1H), 7.87 (s, 1H), 7.78 (d, 1H), 7.75 (dd, 1H), 7.64 (d, 1H), 7.63 (s, 1H), 7.48 (dd, 1H)

[0182] Example 9: Synthesis of 5-chloro-3-fluoro-2-[3-methoxy-2-[4-(trifluoromethyl)pyrazol-1-yl]phenoxy]pyridine (A36).

[0183] Step 1: Synthesis of 1-(2-methoxyphenyl)-4-(trifluoromethyl)pyrazole

[0184]

[0185] A solution of 4-(trifluoromethyl)-1H-pyrazole (291 mg, 2.14 mmol), 1-bromo-2-methoxy-benzene (200 mg, 1.07 mmol), Cu(I)I (204 mg, 1.07 mmol), N,N'-dimethylethane-1,2-diamine (188 mg, 2.14 mmol) and KCO (227 mg, 2.25 mmol) in 1,4-dioxane (20 mL) was heated under reflux for 18 hours. The reaction was cooled to room temperature and evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography on silica gel using a gradient of 5%-50% of EtOAc in cyclohexane as eluent to give the desired product (169 mg, 65%) as a colorless oil.

[0186] 1 H NMR (400MHz, CDCl3) δ = 8.31 (s, 1H), 7.88 (s, 1H), 7.72 (d, 1H), 7.36 (t, 1H), 7.11-7.03 (m, 2H), 3.91 (s, 3H).

[0187] Step 2: Synthesis of [3-methoxy-2-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetate

[0188]

[0189] A solution of 1-(2-methoxyphenyl)-4-(trifluoromethyl)pyrazole (326 mg, 1.35 mmol), Pd(OAc)2(31 mg, 0.13 mmol) and (diacetoxyiodo)benzene (1.77 g, 5.38 mmol) in acetic acid (13.5 mL) was heated at 100 ° C for 2 hours. The reaction was cooled to room temperature, then evaporated to dryness under reduced pressure and azeotroped with toluene three times. The crude product was purified by flash chromatography on silica gel using a gradient of 5%-100% of EtOAc in cyclohexane as eluent to give the desired product (292 mg, 72%) as a yellow solid.

[0190] 1 H NMR (400MHz, CDCl3) δ = 7.90 (s, 1H), 7.81 (s, 1H), 7.46 (t, 1H), 6.95 (d, 1H), 6.85 (d, 1H), 3.83 (s, 3H), 2.08 (s, 3H)

[0191] Step 3: Synthesis of 3-methoxy-2-[4-(trifluoromethyl)pyrazol-1-yl]phenol

[0192]

[0193] A solution of [3-methoxy-2-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetate (295 mg, 0.95 mmol) and NaOH (133 mg, 3.32 mmol) in MeOH (5.7 mL) and H2O (0.57 mL) was stirred at room temperature overnight. The reaction was diluted with water, made acidic with 2M HCl and extracted with DCM (×3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure to give the desired product (245 mg, quantitative) which was used without further purification.

[0194] 1 H NMR (400MHz, CDCl3)δ=10.1(br,1H),8.52(s,1H),7.91(s,1H),7.17(t,1H),6.74(d,1H),6.59(d,1H),3.91(s,3H)

[0195] Step 4: Synthesis of 5-chloro-3-fluoro-2-[3-methoxy-2-[4-(trifluoromethyl)pyrazol-1-yl]phenoxy]pyridine (A36)

[0196]

[0197] A solution of 3-methoxy-2-[4-(trifluoromethyl)pyrazol-1-yl]phenol (150 mg, 0.58 mmol), 5-chloro-2,3-difluoro-pyridine (104 mg, 0.70 mmol) and K2CO3 (161 mg, 1.16 mmol) in DMF (2 mL) was heated at 80 ° C for 18 hours. The reaction was cooled to room temperature, diluted with water and extracted with EtOAc (× 3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography on silica gel using a gradient of 5%-30% of EtOAc in cyclohexane as eluent to give the desired product (169 mg, 75%) as a colorless gum.

[0198] 1 H NMR (400MHz, CDCl3) δ = 7.78 (s, 1H), 7.72 (s, 2H), 7.47 (t, 1H), 7.39 (dd, 1H), 7.00-6.91 (m, 2H), 3.83 (s, 3H)

[0199] Example 10: Synthesis of 5-chloro-3-fluoro-2-[3-iodo-2-[4-(trifluoromethyl)pyrazol-1-yl]phenoxy]pyridine (A57)

[0200] Step 1: Synthesis of 1-(2-iodo-6-methoxy-phenyl)-4-(trifluoromethyl)pyrazole

[0201]

[0202] A solution of 1-(2-methoxyphenyl)-4-(trifluoromethyl)pyrazole (270 mg, 1.11 mmol), Pd(OAc)2 (26 mg, 0.11 mmol) and N-iodosuccinimide (284 mg, 1.23 mmol) in acetic acid (11.5 mL) was heated at 100 ° C for 2 hours. The reaction was cooled to room temperature, then evaporated to dryness under reduced pressure and azeotroped with toluene three times. The crude product was purified by flash chromatography on silica gel using a gradient of 5%-30% of EtOAc in cyclohexane as eluent to give the desired product (397 mg, 97%) as a light yellow gum.

[0203] 1 H NMR (400MHz, CDCl3) δ = 7.95 (s, 1H), 7.75 (s, 1H), 7.52 (d, 1H), 7.16 (t, 1H), 7.00 (d, 1H), 3.77 (s, 3H)

[0204] Step 2: Synthesis of 3-iodo-2-[4-(trifluoromethyl)pyrazol-1-yl]phenol

[0205]

[0206] To a solution of 1-(2-iodo-6-methoxy-phenyl)-4-(trifluoromethyl)pyrazole (234 mg, 0.64 mmol) in dichloromethane (12.5 mL) was added BBr (1M solution in DCM) (1.59 mL, 1.59 mmol) dropwise under a nitrogen atmosphere. The reaction mixture was stirred at room temperature for 2.5 hours and then quenched with water. The reaction was basified with saturated aqueous sodium bicarbonate solution and extracted with DCM (×3). The combined organic extracts were washed with brine, dried over MgSO and evaporated to dryness under reduced pressure to give the desired product (228 mg, quantitative) as a beige solid, which was used without further purification.

[0207] 1 H NMR (400MHz, CDCl3) δ = 8.20 (s, 1H), 8.02 (s, 1H), 7.51 (d, 1H), 7.11-7.01 (m, 2H)

[0208] Step 3: Synthesis of 5-chloro-3-fluoro-2-[3-iodo-2-[4-(trifluoromethyl)pyrazol-1-yl]phenoxy]pyridine (A57)

[0209]

[0210] A solution of 3-iodo-2-[4-(trifluoromethyl)pyrazol-1-yl]phenol (228 mg, 0.64 mmol), 5-chloro-2,3-difluoro-pyridine (116 mg, 0.77 mmol) and K2CO3 (178 mg, 1.29 mmol) in DMF (2 mL) was heated at 80 ° C for 18 hours. The reaction was cooled to room temperature, diluted with water and extracted with EtOAc (× 3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography on silica gel using a gradient of 5%-30% of EtOAc in cyclohexane as eluent to give the desired product (210 mg, 67%) as a white solid.

[0211] 1 H NMR (400MHz, CDCl3δ=7.88(dd,1H),7.80(dd,2H),7.72(s,1H),7.40(dd,1H),7.36-7.22(m,2H)

[0212] Example 11: Synthesis of 5-chloro-2-[2-(5-chloro-2-thienyl)phenoxy]-3-fluoro-pyridine (A66)

[0213] Step 1: Synthesis of 2-chloro-5-(2-methoxyphenyl)thiophene

[0214]

[0215] Under N2 atmosphere, a degassed solution of 1-iodo-2-methoxy-benzene (500 mg, 2.14 mmol), (5-chloro-2-thienyl)boronic acid (416 mg, 2.56 mmol), Pd(OAc)2 (25 mg, 0.11 mmol), 2-dicyclohexylphosphino-2'-methylbiphenyl (MePhos) (159 mg, 0.43 mmol) and KF (372 mg, 6.41 mmol) in 1,4-dioxane (7.5 mL) was heated under reflux for 18 hours. The reaction was cooled to room temperature, diluted with water and extracted with EtOAc (× 3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography on silica gel using a gradient of 5%-15% of EtOAc in cyclohexane as an eluent to give the desired product (438 mg, 91%) as an orange oil.

[0216] 1 H NMR (400MHz, CDCl3δ=7.58(d,1H),7.28-7.20(m,2H),7.02-6.92(m,2H),6.88(d,1H),3.92(s,3H)

[0217] Step 2: Synthesis of 2-(5-chloro-2-thienyl)phenol

[0218]

[0219] To a solution of 2-chloro-5-(2-methoxyphenyl)thiophene (438 mg, 1.95 mmol) in DCM (39 mL) was added BBr (1 M solution in DCM) (4.87 mL, 4.87 mmol) dropwise under N2 atmosphere. The reaction mixture was stirred for 3 hours and then quenched with water, made basic with saturated aqueous sodium bicarbonate solution and extracted with EtOAc (×3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure to give an orange solid (559 mg) which was used without further purification.

[0220] Step 3: Synthesis of 5-chloro-2-[2-(5-chloro-2-thienyl)phenoxy]-3-fluoro-pyridine (A66)

[0221]

[0222] The crude 2-(5-chloro-2-thienyl)phenol (559 mg), 5-chloro-2,3-difluoro-pyridine (476 mg, 3.18 mmol) and KCO (733 mg, 5.31 mmol) from step 2 above were heated in a stirred solution in DMF (5 mL) at 80 ° C for 18 hours. The reaction was cooled to room temperature, diluted with water and extracted with EtOAc (× 3). The combined organic extracts were washed with brine, dried over MgSO and evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography on silica gel using a gradient of 5%-25% of EtOAc in cyclohexane as eluent and a gradient of 0%-10% of EtOAc in cyclohexane as eluent to give the desired product (51 mg) as an orange gum.

[0223] 1 H NMR (400MHz, CDCl3) δ = 7.81 (s, 1H), 7.62 (d, 1H), 7.51 (d, 1H), 7.40-7.22 (m, 2H), 7.19-7.11 (m, 2H), 6.82 (s, 1H)

[0224] Example 12: Synthesis of 5-chloro-3-fluoro-2-[2-[4-(trifluoromethyl)-2-thienyl]phenoxy]pyridine (A97)

[0225] Step 1: Synthesis of 2-(2-methoxyphenyl)-4-(trifluoromethyl)thiophene

[0226]

[0227] A degassed solution of 3-(trifluoromethyl)thiophene (0.56 g, 3.68 mmol), 1-bromo-2-methoxybenzene (0.688 g, 3.68 mmol), K2CO3 (0.771 g, 5.52 mmol), Pd(OAc)2 (17 mg, 0.076 mmol), pivalic acid (0.128 mL, 1.10 mmol) and tricyclohexylphosphine tetrafluoroborate (54 mg, 0.147 mmol) in N,N-dimethylacetamide (12 mL) was heated at 100°C for 18 hours under N2 atmosphere. The reaction was cooled to room temperature, diluted with water and extracted with EtOAc (×3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure. The crude product was purified twice by flash chromatography on silica gel using a gradient of EtOAc in cyclohexane 0%-5% both times to give the desired product (210 mg, 22%) as a light yellow oil.

[0228] 1H NMR (400MHz, CDCl3) δ7.69-7.61(m,2H),7.58(s,1H),7.30(t,1H),7.04-6.97(m,2H),3.94(s,3H)

[0229] Step 2: Synthesis of 2-[4-(trifluoromethyl)-2-thienyl]phenol

[0230]

[0231] Under N2 atmosphere, 1-dodecanethiol (0.397mL, 1.626mmol) and lithium tert-butoxide (1M in THF) (1.6mL, 1.6mmol) were added to a solution of 2-(2-methoxyphenyl)-4-(trifluoromethyl)thiophene (210mg, 0.81mmol) in DMF (2.5mL). The reaction mixture was heated at 100°C for 18 hours. The reaction mixture was cooled to room temperature, diluted with water and extracted with EtOAc (×3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography on silica gel using a gradient of 0%-20% of EtOAc in cyclohexane as eluent to give the desired product (189mg, 95%) as a yellow oil.

[0232] 1 H NMR (400MHz, CDCl3)δ=7.71(s,1H),7.52(s,1H),7.48(d,1H),7.29-7.20(m,1H),6.97(t,1H),6.91(d,1H),5.34(s,1H)

[0233] Step 3: Synthesis of 5-chloro-3-fluoro-2-[2-[4-(trifluoromethyl)-2-thienyl]phenoxy]pyridine (A97)

[0234]

[0235] A solution of 2-[4-(trifluoromethyl)-2-thienyl]phenol (174 mg, 0.71 mmol), 5-chloro-2,3-difluoro-pyridine (128 mg, 0.86 mmol) and K2CO3 (197 mg, 1.43 mmol) in DMF (5 mL) was heated at 140 ° C for 30 minutes under microwave irradiation. The reaction was cooled to room temperature, diluted with water and extracted with EtOAc (× 3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography twice on silica gel using a gradient of 0%-5% of EtOAc in cyclohexane as eluent followed by a gradient of 0%-30% of DCM in cyclohexane as eluent to give the desired product (136 mg, 51%) as a colorless gum.

[0236] 1 H NMR (400MHz, CDCl3)δ=7.80(s,1H),7.69(d,1H),7.61(s,1H),7.52-7.48(m,2H),7.40(t,1H),7.31(t,1H),7.20(d,1H)

[0237] Example 13: Synthesis of 2-[2-[3,5-bis(trifluoromethyl)pyrazol-1-yl]phenoxy]-5-chloro-3-fluoro-pyridine (A123)

[0238] Step 1: Synthesis of 1-(2-methoxyphenyl)-3,5-bis(trifluoromethyl)pyrazole

[0239]

[0240] A solution of (2-methoxyphenyl)hydrazine hydrochloride (500mg, 2.86mmol) and 1,1,1,5,5,5-hexafluoropentane-2,4-dione (596mg, 2.86mmol) in EtOH (3.6mL) and concentrated H2SO4 (0.1mL) was heated under reflux for 18 hours. The reaction was cooled to room temperature, diluted with water and extracted with EtOAc (×3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography on silica gel using a gradient of 0%-50% of EtOAc in cyclohexane as a gradient to give the desired product (101mg, 11%) as a yellow oil.

[0241] 1 H NMR (400MHz, CDCl3δ=7.52(t,1H),7.34(d,1H),7.09-7.00(m,3H),3.79(s,3H)

[0242] Step 2: Synthesis of 2-[3,5-bis(trifluoromethyl)pyrazol-1-yl]phenol

[0243]

[0244] To a stirred solution of 1-(2-methoxyphenyl)-3,5-bis(trifluoromethyl)pyrazole (101 mg, 0.33 mmol) in dichloromethane (6.5 mL) was added boron tribromide (1 M solution in DCM) (0.81 mL, 0.81 mmol) dropwise under N2 atmosphere. The reaction was stirred at room temperature overnight. The reaction mixture was quenched with water and extracted with DCM (×3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure to give the desired product (91 mg, 94%) as a yellow gum, which was used without further purification.

[0245] 1 H NMR (400MHz, CDCl3) δ = 7.45-7.30 (m, 2H), 7.18-7.07 (m, 2H), 7.02 (t, 1H), 6.32 (s, 1H)

[0246] Step 3: Synthesis of 2-[2-[3,5-bis(trifluoromethyl)pyrazol-1-yl]phenoxy]-5-chloro-3-fluoro-pyridine (A123)

[0247]

[0248] A solution of 2-[3,5-bis(trifluoromethyl)pyrazol-1-yl]phenol (97 mg, 0.23 mmol), 5-chloro-2,3-difluoro-pyridine (55 mg, 0.35 mmol) and K2CO3 (85 mg, 0.61 mmol) in DMF (5 mL) was heated at 140 ° C for 30 minutes under microwave irradiation. The reaction was cooled to room temperature, diluted with water and extracted with EtOAc (× 3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography on silica gel using a gradient of 0%-10% of EtOAc in cyclohexane as eluent to give the desired product (97 mg, 75%) as a brown gum.

[0249] 1 H NMR (400MHz, CDCl3δ=7.84(s,1H),7.61(t,1H),7.52(d,1H),7.45(d,1H),7.43-7.35(m,2H),6.96(s,1H)

[0250] Example 14: Synthesis of 2-[2-[(5-chloro-3-fluoro-2-pyridyl)oxy]phenyl]thiazole (A147)

[0251] Step 1: Synthesis of 2-thiazol-2-ylphenol

[0252]

[0253] A degassed solution of 2-chlorothiazole (260 mg, 2.18 mmol), (2-hydroxyphenyl)boronic acid (250 mg, 1.81 mmol), Na2CO3 (576 mg, 5.44 mmol), tetrakis(triphenylphosphine)palladium (21 mg, 0.018 mmol) in toluene (2.5 mL), EtOH (2.5 mL) and water (1.25 mL) was heated at 160 ° C for 30 minutes under microwave irradiation. The reaction was cooled to room temperature, diluted with water and extracted with EtOAc (× 3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography on silica gel using a gradient of 0%-50% of EtOAc in cyclohexane as eluent to give the desired product (127 mg, 40%) as a light green oil.

[0254] 1 H NMR (400MHz, CDCl3) δ = 12.3 (s, 1H), 7.79 (s, 1H), 7.63 (d, 1H), 7.35-7.21 (m, 2H), 7.05 (d, 1H), 6.90 (t, 1H)

[0255] Step 2: Synthesis of 2-[2-[(5-chloro-3-fluoro-2-pyridyl)oxy]phenyl]thiazole (A147)

[0256]

[0257] A solution of 2-thiazol-2-ylphenol (127 mg, 0.72 mmol), 5-chloro-2,3-difluoro-pyridine (129 mg, 0.86 mmol) and K2CO3 (198 mg, 1.43 mmol) in DMF (5 mL) was heated at 140 ° C for 30 minutes under microwave irradiation. The reaction was cooled to room temperature, diluted with water and extracted with EtOAc (× 3). The combined organic extracts were washed with brine, dried over MgSO4 and evaporated to dryness under reduced pressure. The crude product was purified by flash chromatography on silica gel using a gradient of 0%-20% of EtOAc in cyclohexane as eluent to give the desired product (208 mg, 95%) as a light yellow oil.

[0258] 1H NMR (400MHz, CDCl3)δ=8.42(d,1H),7.88(s,1H),7.73(s,1H),7.55(d,1H),7.46(t,1H),7.41-7.32(m,2H),7.21(d,1H)

[0259] Table 1 - Examples of herbicidal compounds of the present invention.

[0260]

[0261]

[0262]

[0263]

[0264]

[0265]

[0266]

[0267]

[0268]

[0269]

[0270]

[0271]

[0272]

[0273]

[0274]

[0275]

[0276]

[0277]

[0278]

[0279]

[0280] Biological Examples

[0281] Seeds of various test species were sown in standard soil in pots (Lolium perenne (LOLPE), Solanum nigrum (SOLNI), Amaranthus retoflexus (AMARE), Setaria faberi (SETFA), Echinochloa crus-galli (ECHCG), Ipomoea hederacea (IPOHE)). After one day of cultivation (pre-emergence) or eight days of cultivation (post-emergence) in a greenhouse under controlled conditions (24°C / 16°C day / night; 14 h light; 65% humidity), the plants were sprayed with an aqueous spray solution derived from a formulation of technical grade active ingredient in acetone / water (50:50) solution containing 0.5% Tween 20 (polyoxyethylene sorbitan monolaurate, CAS RN9005-64-5). Unless otherwise stated, the compound is applied at 500 g / ha. The test plants are then grown in a greenhouse under controlled conditions (at 24°C / 16°C day / night; 14 hours of light; 65% humidity) and watered twice a day. For pre-emergence and 13 days after emergence, the percentage of damage to the plant caused by the test is evaluated. The biological activity is shown in the following table in a five-point system (5 = 81%-100%; 4 = 61%-80%; 3 = 41%-60%; 2 = 21%-40%; 1 = 0%-20%).

[0282] Table B1. Post-emergence tests

[0283]

[0284]

[0285]

[0286]

[0287] NT = Not Tested

[0288] Table B2. Pre-emergence test

[0289]

[0290]

[0291]

[0292]

[0293] NT = Not Tested

[0294] Table B3. Comparison test

[0295] Biological Examples

[0296] Seeds of various test species were sown in standard soil in pots. After one day of cultivation under controlled conditions in a greenhouse (24°C / 16°C, day / night; 14 hours of light; 65% humidity) (pre-emergence), the plants were sprayed with an aqueous spray solution derived from a formulation of technical grade active ingredients in 0.6 ml of acetone and 45 ml of formulation solution containing 10.6% Emulsogen EL (registration number 61791-12-6), 42.2% N-methylpyrrolidone, 42.2% dipropylene glycol monomethyl ether (CAS RN 34590-94-8) and 0.2% X-77 (CAS RN 11097-66-8).

[0297] The test plants are then grown in a greenhouse under controlled conditions in the greenhouse (24°C / 16°C, day / night; 14 hours of light; 65% humidity) and watered twice a day. After 21 days, the test is evaluated (100 = complete damage to the plant; 0 = no plant damage).

[0298] Test plants:

[0299] Weed species: Amaranthus retroflexus (AMARE)

[0300] Crop: Soybean (Jack Soybean (Glycine max) (GLYMA))

[0301] The results demonstrate that the pyridine compounds of the present invention exhibit greatly reduced herbicidal damage to crops (soybeans) compared to prior art pyrimidine compounds, while weed (AMARE) control remains comparable.

[0302]

[0303]

Claims

1. A compound having formula (I): or an agronomically acceptable salt thereof, in Q is a 5-membered aromatic heterocyclic ring, which is optionally substituted by 1 or 2 R independently selected from the group consisting of 3 Substituent substitution: C 1 -C 4 Alkyl, C 2 -C 4 Alkenyl, C 2 -C 4 Alkynyl, cyclopropyl, C 1 -C 4 Haloalkyl, C 1 -C 2 Alkoxy-, C 1 -C 2 Haloalkoxy-, halogen, -C(O)C 1 -C 4 Alkyl, NO 2 、-CH 2 CN, -CN, and -S(O) p C 1 -C 4 alkyl; Each R 1 are independently selected from the group consisting of: halogen, -CN, nitro, C 1 -C 4 Alkyl, C 2 -C 4 Alkenyl, C 2 -C 4 Alkynyl, C 1 -C 4 Haloalkyl, C 1 -C 4 Alkoxy-, C 1 -C 4 Haloalkoxy- and -S(O) p C 1 -C 4 alkyl; Each R 2 independently selected from the group consisting of halogen, -CN, NO 2 , C 1 -C 4 Alkyl, C 1 -C 4 Haloalkyl, C 3 -C 6 Cycloalkyl, C 2 -C 4 Alkenyl, C 2 -C 4 Alkynyl, -S(O) p C 1 -C 4 Alkyl, C 1 -C 4 Alkoxy, -C(O)C 1 -C 4 Alkyl, -C(O)OC 1 -C 4 Alkyl and C 1 -C 4 Haloalkoxy; m = 0, 1 or 2; n = 0, 1 or 2; and p = 0, 1 or 2; with the proviso that Q is not 1,3,4-oxadiazol-2-yl or C-attached tetrazolyl, and wherein if Q is 2-thienyl or 2-furyl, the 2-thienyl or 2-furyl is replaced by 1 or 2 independently selected from C 1 -C 2 R is a group consisting of haloalkyl, halogen and -CN 3 replace.

2. The compound of formula (I) according to claim 1, in, Q is selected from the group consisting of: Where R 3 Selected from the group consisting of: hydrogen, C 1 -C 4 Alkyl, C 2 -C 4 Alkenyl, C 2 -C 4 Alkynyl, cyclopropyl, C 1 -C 2 Haloalkyl, C 1 -C 2 Alkoxy-, C 1 -C 2 Haloalkoxy-, halogen, -C(O)C 1 -C 4 Alkyl, NO 2 、-CH 2 CN, -CN, and -S(O) p C 1 -C 4 Alkyl; and R 3a is hydrogen or C 1 -C 2 alkyl with the proviso that Q is not 1,3,4-oxadiazol-2-yl or C-attached tetrazolyl, and wherein if Q is 2-thienyl or 2-furyl, the 2-thienyl or 2-furyl is replaced by 1 or 2 independently selected from C 1 -C 2 R is a group consisting of haloalkyl, halogen and -CN 3 replace.

3. The compound of formula (I) according to claim 2, in, Q is selected from the group consisting of Q19, Q20 and Q34.

4. The compound of formula (I) according to claim 2, in, Q is Q20.

5. The compound according to claim 1, in, n is 1 and R 1 It's fluorine.

6. The compound according to claim 5, in, R 1 It is 3-fluoro.

7. The compound according to claim 1, in, m is 1 or 2, and R 2 Independently selected from the group consisting of fluoro, nitro, cyano and trifluoromethyl.

8. The compound according to claim 1, in, R 3 It is difluoromethyl or trifluoromethyl.

9. A herbicidal composition comprising the compound according to claim 1 and an agriculturally acceptable formulation adjuvant.

10. The herbicidal composition according to claim 9, further comprising at least one additional pesticide.

11. The herbicidal composition according to claim 10, in, The additional pesticide is a herbicide or a herbicide safener.

12. A method of controlling weeds at a locus, the method comprising applying to the locus a weed controlling amount of a composition according to any one of claims 9 to 11.

13. Use of the compound of formula (I) according to claim 1 as a herbicide.